Growth Metrics

Ani Pharmaceuticals (ANIP) Other Working Capital Changes (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Other Working Capital Changes for 16 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 163.44% to $4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, up 335.98% year-over-year, with the annual reading at $5.0 million for FY2025, 335.98% up from the prior year.
  • Other Working Capital Changes hit $4.5 million in Q4 2025 for Ani Pharmaceuticals, down from $6.5 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $8.4 million in Q4 2023 to a low of -$9.8 million in Q2 2025.
  • Historically, Other Working Capital Changes has averaged $629050.0 across 5 years, with a median of -$77500.0 in 2021.
  • Biggest YoY gain for Other Working Capital Changes was 415.6% in 2025; the steepest drop was 2219.58% in 2025.
  • Year by year, Other Working Capital Changes stood at $1.3 million in 2021, then soared by 163.91% to $3.4 million in 2022, then skyrocketed by 145.36% to $8.4 million in 2023, then tumbled by 79.79% to $1.7 million in 2024, then surged by 163.44% to $4.5 million in 2025.
  • Business Quant data shows Other Working Capital Changes for ANIP at $4.5 million in Q4 2025, $6.5 million in Q3 2025, and -$9.8 million in Q2 2025.